Adaptation of SARS-CoV-2 to ACE2 H353K mice reveals new spike residues that drive mouse infection
Journal of Virology · 2024
DOI: 10.1128/jvi.01510-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Kun Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The University of Iowa, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
The Coronavirus Disease 2019 (COVID-19) pandemic continues to cause extraordinary loss of life and economic damage. Animal models of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection are needed to better understand disease pathogenesis and evaluate preventive measures and therapies. While mice are widely used to model human disease, mouse angiotensin converting enzyme 2 (ACE2) does not bind the ancestral SARS-CoV-2 spike protein to mediate viral entry. To overcome this limitation, we “humanized” mouse Ace2 using CRISPR gene editing to introduce a single amino acid substitution, H353K, predicted to facilitate S protein binding. While H353K knockin Ace2 (mACE2 H353K ) mice supported SARS-CoV-2 infection and replication, they exhibited minimal disease manifestations. Following 30 serial passages of ancestral SARS-CoV-2 in mACE2 H353K mice, we generated and cloned a more virulent virus. A single isolate (SARS2 MA-H353K ) was prepared for detailed studies. In 7–11-month-old mACE2 H353K mice, a 10 4 PFU inocula resulted in diffuse alveolar disease manifested as edema, hyaline membrane formation, and interstitial cellular infiltration/thickening. Unexpectedly, the mouse-adapted virus also infected standard BALB/c and C57BL/6 mice and caused severe disease. The mouse-adapted virus acquired five new missense mutations including two in spike (K417E, Q493K), one each in nsp4, nsp9, and M and a single nucleotide change in the 5′ untranslated region. The Q493K spike mutation arose early in serial passage and is predicted to provide affinity-enhancing molecular interactions with mACE2 and further increase the stability and affinity to the receptor. This new model and mouse-adapted virus will be useful to evaluate COVID-19 disease and prophylactic and therapeutic interventions. IMPORTANCE We developed a new mouse model with a humanized angiotensin converting enzyme 2 (ACE2) locus that preserves native regulatory elements. A single point mutation in mouse ACE2 (H353K) was sufficient to confer in vivo infection with ancestral severe acute respiratory syndrome-coronavirus-2 virus. Through in vivo serial passage, a virulent mouse-adapted strain was obtained. In aged mACE2H353K mice, the mouse-adapted strain caused diffuse alveolar disease. The mouse-adapted virus also infected standard BALB/c and C57BL/6 mice, causing severe disease. The mouse-adapted virus acquired five new missense mutations including two in spike (K417E, Q493K), one each in nsp4, nsp9, and M and a single nucleotide change in the 5′ untranslated region. The Q493K spike mutation arose early in serial passage and is predicted to provide affinity-enhancing molecular interactions with mACE2 and further increase the stability and affinity to the receptor. This new model and mouse-adapted virus will be useful to evaluate COVID-19 disease and prophylactic and therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, The University of Iowa, Iowa City, Iowa, USA.
- Department of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, USA.
- Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA.
- Protein and Crystallography Facility, The University of Iowa, Iowa City, Iowa, USA.
- Department of Internal Medicine, The University of Iowa, Iowa City, Iowa, USA.
- Department of Pathology, The University of Iowa, Iowa City, Iowa, USA.
ORCID-Profile: Kun Li, Tom Gallagher, Stanley Perlman, Paul B McCray
Förderung
- NIEHS NIH HHS
- NIAID NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
- HHS | National Institutes of Health
Zitieren
APA
Li, K., Verma, A., Li, P., Ortiz, M. E., Hawkins, G. M., Schnicker, N. J., Szachowicz, P. J., Pezzulo, A. A., Wohlford-Lenane, C. L., Kicmal, T., Meyerholz, D. K., Gallagher, T., Perlman, S., & McCray, P. B. (2024). Adaptation of SARS-CoV-2 to ACE2 H353K mice reveals new spike residues that drive mouse infection. Journal of Virology. https://doi.org/10.1128/jvi.01510-23
Vancouver
Li K, Verma A, Li P, Ortiz ME, Hawkins GM, Schnicker NJ, et al. Adaptation of SARS-CoV-2 to ACE2 H353K mice reveals new spike residues that drive mouse infection. Journal of Virology. 2024. doi:10.1128/jvi.01510-23
BibTeX
@article{Li2024,
author = {Li, Kun and Verma, Abhishek and Li, Pengfei and Ortiz, Miguel E and Hawkins, Grant M and Schnicker, Nicholas J and Szachowicz, Peter J and Pezzulo, Alejandro A and Wohlford-Lenane, Christine L and Kicmal, Tom and Meyerholz, David K and Gallagher, Tom and Perlman, Stanley and McCray, Paul B},
title = {Adaptation of SARS-CoV-2 to ACE2 H353K mice reveals new spike residues that drive mouse infection},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.01510-23}
}
EUVIMED